Count | |
| 1 | |
| 2 | |
| 1 | |
Tissue Kallikreins/administration & dosage/blood/*genetics/urine | 1 |
| 24 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 12 | |
| 1 | |
| 1 | |
| 2 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Tissue Kallikreins/*chemistry/classification/genetics/*metabolism | 1 |
Tissue Kallikreins/biosynthesis/genetics/metabolism/*secretion | 1 |
| 46 | |
| 1 | |
| 5 | |
| 1 | |
| 2 | |
| 2 | |
| 2 | |
| 5 | |
| 2 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Tissue Kallikreins/analysis/antagonists & inhibitors/*physiology | 1 |
Tissue Kallikreins/antagonists & inhibitors/metabolism/*physiology | 1 |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 8 | |
| 3 | |
| 1 | |
| 3 | |
| 2 | |
| 1 | |
| 1 | |
Kallikreins/antagonists & inhibitors/*blood/isolation & purification | 1 |
Kallikreins/*antagonists & inhibitors/blood/chemistry/*metabolism | 1 |
Kallikreins/antagonists & inhibitors/*blood/*pharmacology/toxicity | 1 |
| 25 | |
| 7 | |
| 3 | |
| 9 | |
| 4 | |
| 3 | |
| 1 | |
| 2 | |
| 1 | |
| 3 | |
| 6 | |
| 1 | |
| 5 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
Tissue Plasminogen Activator/blood/genetics/*pharmacokinetics | 1 |
Nerve Tissue Proteins/blood/genetics/*isolation & purification | 1 |
Tissue Inhibitor of Metalloproteinase-2/*blood/drug effects/genetics | 1 |
| 8 | |
| 15 | |
| 1 | |
| 2 | |